AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- A new non-hormonal drug, Fezzolina tan, has been FDA-approved to reduce menopausal hot flashes effectively within four weeks.
- Societal silence and lack of open dialogue around menopause emphasize the need for normalized conversations and increased awareness.
Deep dives
Menopause Treatment Advancement
A new FDA-approved non-hormonal drug, Fezzolina tan, has been introduced to effectively reduce hot flashes associated with menopause, offering relief within four weeks. This groundbreaking advancement addresses a common yet often overlooked side effect of menopause that impacts half of the global population. The drug's efficacy has been celebrated for its significant reduction in hot flash symptoms, providing hope for individuals experiencing menopausal discomfort.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode